Tailoring treatment for multiple myeloma patients with relapsed and refractory disease.

Oncology (Williston Park, N.Y.)

Volumn 24, Issue 3 Suppl 2, 2010, Pages 22-29

  Richardson, Paul G ^a   Laubach, Jacob ^b   Mitsiades, Constantine ^b   Schlossman, Robert L ^b   Doss, Deborah ^b   Colson, Kathleen ^b   McKenney, Mary L ^b   Noonan, Kimberly ^b   Warren, Diane L ^b   Ghobrial, Irene M ^b   Munshi, Nikhil C ^b   Anderson, Kenneth ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CLINICAL TRIAL; DRUG RESISTANCE; HUMAN; MULTIPLE MYELOMA; PERSONALIZED MEDICINE; SALVAGE THERAPY; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE, NEOPLASM; HUMANS; INDIVIDUALIZED MEDICINE; MULTIPLE MYELOMA; NEOPLASM RECURRENCE, LOCAL; SALVAGE THERAPY;

EID: 77953935296     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)